IRIS
CENTONZE, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 202
EU - Europa 139
AS - Asia 77
SA - Sud America 1
Totale 419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 192
DE - Germania 78
SG - Singapore 69
IT - Italia 36
GB - Regno Unito 11
CA - Canada 9
BE - Belgio 7
LT - Lituania 6
BD - Bangladesh 4
HK - Hong Kong 3
BR - Brasile 1
IL - Israele 1
MX - Messico 1
NL - Olanda 1
Totale 419
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 77
West Jordan 66
Singapore 40
Boardman 39
Brussels 7
Buffalo 7
London 6
Rome 6
Naples 5
Toronto 5
Ashburn 4
Bologna 4
Ottawa 4
Sant'Elpidio a Mare 4
Arosio 3
Charlotte 3
Hong Kong 3
Zona Industriale 2
Council Bluffs 1
Ettlingen 1
Kiryat Ono 1
Los Angeles 1
Mexico City 1
Milan 1
Raviscanina 1
São Paulo 1
Totale 293
Salva come PNG Salva come JPEG
Nome #
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 18
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 16
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 15
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 14
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 13
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 13
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 11
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 11
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 10
Amyloid-β homeostasis bridges inflammation, synaptic plasticity deficits and cognitive dysfunction in multiple sclerosis 10
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 10
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 10
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 10
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 10
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 10
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 10
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 10
Case Report: Overlap Between Long COVID and Functional Neurological Disorders 10
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 9
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 9
Dopaminergic dysfunction is associated with IL-1??-dependent mood alterations in experimental autoimmune encephalomyelitis 9
Osteopontin Is Associated with Multiple Sclerosis Relapses 9
Interaction between interleukin-1?? and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 9
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 9
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 9
Obesity worsens central inflammation and disability in multiple sclerosis 9
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 9
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 9
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 8
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 8
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 8
Synaptic plasticity shapes brain connectivity: Implications for network topology 8
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 8
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 8
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 7
Subclinical dysphagia in task-specific mouth tremor triggered by drinking 7
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 7
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 7
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 7
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 7
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 7
Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis 6
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 6
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 5
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 5
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 5
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 5
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 5
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 5
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 5
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 5
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 4
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 4
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 4
miR-142-3p Is a Key Regulator of IL-1??-Dependent Synaptopathy in Neuroinflammation 4
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 4
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 4
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 3
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 3
Interleukin-1 Alters Glutamate Transmission at Purkinje Cell Synapses in a Mouse Model of Multiple Sclerosis 3
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 3
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 3
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 3
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 3
Totale 495
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024219 0 0 0 0 0 0 52 0 0 137 15 15
2024/2025276 40 49 7 69 105 6 0 0 0 0 0 0
Totale 495